May 19, 2022
RegMed Investors’ (RMi) closing bell: sector was kicked, but not put on its butt
May 18, 2022
RegMed Investors’ (RMi) closing bell: Tuesday was a short-lived rally as sector equities plummet Wednesday
May 17, 2022
RegMed Investors’ (RMi) closing bell: enjoying the cell and gene therapy sector high and I didn’t even inhale
May 13, 2022
RegMed Investors’ (RMi) closing bell: session two (2) in a row of three (3) positive closes in the week
May 12, 2022
RegMed Investors’ (RMi) closing bell: miracle moves, the oversold ascended to the upside
May 11, 2022
RegMed Investors’ (RMi) closing bell: sector pricing was taken to the woodshed and whupped
May 10, 2022
RegMed Investors’ (RMi) closing bell: a bounce to the upside
May 4, 2022
RegMed Investors’ (RMi) closing bell: a wild and volatile sector ride that ended to the upside
May 2, 2022
RegMed Investors’ (RMi) closing bell: the oversold were noticed but, for how long?
April 29, 2022
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector dives, TGIF and April is over
April 28, 2022
RegMed Investors’ (RMi) closing bell: gravity was overcome for the cell and gene therapy sector
April 27, 2022
RegMed Investors’ (RMi) closing bell: wherefore art thou sentiment
April 25, 2022
RegMed Investors’ (RMi) closing bell: big share price reversal helps resets the cell and gene therapy sector’s oversold
April 22, 2022
RegMed Investors’ (RMi) closing bell: what happened today, another sector face plant in the mud
April 21, 2022
RegMed Investors’ (RMi) closing bell: market conditions and sector sentiment are hammered
April 20, 2022
RegMed Investors’ (RMi) closing bell: low volume lethargy enables fatigued sentiment hampering some share pricings
April 19, 2022
RegMed Investors’ (RMi) closing bell: the cell and gene therapy sector’s ascension
April 18, 2022
RegMed Investors’ (RMi) closing bell: Why the slide …
April 14, 2022
RegMed Investors’ (RMi) closing bell: closing with a downslide shortened week with Friday market holiday
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors